PL3567099T3 - Populacje komórek nerkowych i ich zastosowania - Google Patents

Populacje komórek nerkowych i ich zastosowania

Info

Publication number
PL3567099T3
PL3567099T3 PL19168775T PL19168775T PL3567099T3 PL 3567099 T3 PL3567099 T3 PL 3567099T3 PL 19168775 T PL19168775 T PL 19168775T PL 19168775 T PL19168775 T PL 19168775T PL 3567099 T3 PL3567099 T3 PL 3567099T3
Authority
PL
Poland
Prior art keywords
cell populations
renal cell
renal
populations
cell
Prior art date
Application number
PL19168775T
Other languages
English (en)
Inventor
Joydeep Basu
Kelly Guthrie
Dominic JUSTEWICZ
Teresa BURNETTE
Andrew Bruce
Russell Kelley
John W. Ludlow
Original Assignee
Prokidney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prokidney filed Critical Prokidney
Publication of PL3567099T3 publication Critical patent/PL3567099T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/02—Aminoacyltransferases (2.3.2)
    • C12Y203/02002—Gamma-glutamyltransferase (2.3.2.2)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
PL19168775T 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania PL3567099T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261718150P 2012-10-24 2012-10-24
US201361876616P 2013-09-11 2013-09-11
PCT/US2013/066707 WO2014066699A1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof
EP19168775.5A EP3567099B1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof
EP13786132.4A EP2912165B1 (en) 2012-10-24 2013-10-24 Renal cell populations and uses thereof

Publications (1)

Publication Number Publication Date
PL3567099T3 true PL3567099T3 (pl) 2021-11-29

Family

ID=49517782

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13786132T PL2912165T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania
PL19168775T PL3567099T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13786132T PL2912165T3 (pl) 2012-10-24 2013-10-24 Populacje komórek nerkowych i ich zastosowania

Country Status (18)

Country Link
US (5) US20150246073A1 (pl)
EP (4) EP3567099B1 (pl)
JP (2) JP6509119B2 (pl)
KR (5) KR20240096798A (pl)
CN (3) CN110184232B (pl)
AU (4) AU2013334276B2 (pl)
BR (2) BR112015009042B1 (pl)
CA (2) CA3240629A1 (pl)
DK (3) DK3567099T3 (pl)
ES (3) ES2744979T3 (pl)
FI (1) FI3901251T3 (pl)
HU (2) HUE046176T2 (pl)
NZ (2) NZ741724A (pl)
PL (2) PL2912165T3 (pl)
PT (1) PT2912165T (pl)
RU (1) RU2702721C2 (pl)
SI (1) SI2912165T1 (pl)
WO (1) WO2014066699A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3567099T3 (da) 2012-10-24 2021-06-07 Prokidney Nyrecellepopulationer og anvendelser deraf
CA3031320A1 (en) * 2016-07-29 2018-02-01 Deepak Jain Bioactive renal cells for the treatment of chronic kidney disease
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
WO2018183199A1 (en) * 2017-03-31 2018-10-04 Deepak Jain Injectable cell and scaffold compositions
KR20250026894A (ko) * 2017-06-21 2025-02-25 티모시 에이. 버트람 신장 질환의 치료를 위한 면역특권화 생체활성 신장 세포
JP7061766B2 (ja) * 2017-09-20 2022-05-02 学校法人同志社 Ｄｊ－１タンパク質産生促進用組成物
CN109266616A (zh) * 2018-08-21 2019-01-25 山西省人民医院 一种稳定表达aqp2蛋白的人源化小鼠足细胞模型及其构建方法和应用
WO2020047071A1 (en) * 2018-08-31 2020-03-05 Timothy Bertram Compositions comprising cell-derived vesicles and uses thereof
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
US20220202867A1 (en) * 2019-05-02 2022-06-30 Timothy Bertram Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies
WO2021152578A1 (en) * 2020-01-28 2021-08-05 Kidneycure Ltd Process for kidney cell manufacture and treatment
IL302862A (en) * 2020-11-13 2023-07-01 Bertram Timothy Enriched bioactive renal cell populations, characteristics and uses thereof
CN116240161B (zh) * 2023-02-27 2024-05-10 四川大学华西医院 具有肾脏损伤修复作用的细胞外囊泡制备方法及应用
AU2024287488A1 (en) * 2023-07-07 2026-01-15 Timothy A. Bertram Selected renal cell populations, characteristics and uses thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1139859A (en) 1914-02-13 1915-05-18 Felix Gottschalk Automatic fire-alarm system.
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
CA2046830C (en) 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
ES2159726T3 (es) 1995-03-10 2001-10-16 Roche Diagnostics Gmbh Formas de administracion farmaceuticas que contienen polipeptidos, en forma de microparticulas, y procedimiento para su fabricacion.
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
AU747166B2 (en) 1997-10-31 2002-05-09 Children's Medical Center Corporation Bladder reconstruction
ATE281155T1 (de) 1998-04-20 2004-11-15 Genzyme Corp Medikamentöse verabreichung von proteinen aus polymergemischen
DE19933582A1 (de) 1999-07-17 2001-01-18 Gerhard Rosenberger Vorrichtung zum Aufnehmen von Werkstücken und/oder Werkzeugen
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US7197470B1 (en) 2000-10-11 2007-03-27 Buzzmetrics, Ltd. System and method for collection analysis of electronic discussion methods
BR0208603A (pt) 2001-04-03 2004-03-02 Merck Patent Gmbh Marcadores de tumor para carcinoma de células renais
JP4358621B2 (ja) 2001-08-08 2009-11-04 泰彦 田畑 細胞と細胞増殖因子とからなる腎臓の再生のための材料
JP2005523888A (ja) * 2002-01-03 2005-08-11 ザ スクリプス リサーチ インスティテュート 癌関連エピトープ
JP4532119B2 (ja) 2002-03-22 2010-08-25 キッセイ薬品工業株式会社 腎疾患の予防又は治療剤
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20040139072A1 (en) 2003-01-13 2004-07-15 Broder Andrei Z. System and method for locating similar records in a database
US20050241012A1 (en) * 2003-10-17 2005-10-27 Nigam Sanjay K Multigene profiling in the kidney to tailor drug therapy
US20050108384A1 (en) 2003-10-23 2005-05-19 Lambert John R. Analysis of message sequences
US7788087B2 (en) 2005-03-01 2010-08-31 Microsoft Corporation System for processing sentiment-bearing text
US20080161231A1 (en) * 2005-03-18 2008-07-03 Kintan Pty. Ltd. Methods and compositions for promoting organ development
WO2006117889A1 (ja) * 2005-04-28 2006-11-09 Stemcell Institute Inc. 移植用臓器の調製方法
EP1987134A4 (en) 2006-02-10 2012-08-01 Tengion Inc EQUIPMENT FOR ORGANIC DESIGN AND AUGMENTATION
US20070214097A1 (en) 2006-02-28 2007-09-13 Todd Parsons Social analytics system and method for analyzing conversations in social media
DK2078073T3 (da) * 2006-10-12 2013-10-28 Ethicon Inc Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
US8048636B2 (en) * 2007-03-05 2011-11-01 Northshore University Healthsystem Methods of screening for modulators of h2-calponin activity
US20080305146A1 (en) 2007-06-08 2008-12-11 Wake Forest University Health Sciences, Selective cell therapy for the treatment of renal failure
RU2373942C2 (ru) * 2007-12-26 2009-11-27 Федеральное государственное учреждение "Научный Центр акушерства, гинекологии и перинатологии Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток
CN105734128B (zh) 2008-02-01 2021-05-18 总医院有限公司 微泡在医学疾病和病况的诊断、预后以及治疗中的用途
AU2009313554B2 (en) 2008-11-04 2015-08-27 Inregen Cell-scaffold constructs
EP2186883A1 (en) * 2008-11-04 2010-05-19 Fresenius Medical Care An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
US8318484B2 (en) * 2008-11-12 2012-11-27 Tengion, Inc. Isolated renal cells and uses thereof
WO2011017685A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney transplant rejection
EP2869069A1 (en) * 2009-11-12 2015-05-06 Tengion, Inc. Rational design of regenerative medicine products
US9334324B2 (en) 2010-02-04 2016-05-10 Agency For Science, Technology And Research Podocalyxin-like-protein-1 binding antibody molecule
CA2797705C (en) 2010-05-03 2019-01-08 Tengion, Inc. Smooth muscle cell constructs
HUE058155T2 (hu) 2010-05-12 2022-07-28 Prokidney Bioaktív vesesejtek
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
CN107823706B (zh) 2010-11-10 2022-02-01 因瑞金公司 用于器官增强的注射制剂
EP2760995B1 (en) * 2011-09-30 2019-08-07 The University Of Miami Renal stem cells isolated from kidney
JP2014532431A (ja) 2011-11-04 2014-12-08 テンジオン， インク． 薬物スクリーニングおよび有効性アッセイ
DK3567099T3 (da) 2012-10-24 2021-06-07 Prokidney Nyrecellepopulationer og anvendelser deraf
WO2014066698A1 (en) 2012-10-24 2014-05-01 Metavana, Inc. Method and system for social media burst classifications
DK2994528T3 (da) * 2013-05-08 2024-02-05 Prokidney Organoider, der omfatter isolerede renale celler og anvendelser deraf
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
KR20250026894A (ko) * 2017-06-21 2025-02-25 티모시 에이. 버트람 신장 질환의 치료를 위한 면역특권화 생체활성 신장 세포
IL302862A (en) * 2020-11-13 2023-07-01 Bertram Timothy Enriched bioactive renal cell populations, characteristics and uses thereof

Also Published As

Publication number Publication date
CN104937095B (zh) 2019-06-07
PL2912165T3 (pl) 2020-01-31
KR102160725B1 (ko) 2020-09-29
EP3567099B1 (en) 2021-04-21
EP4527921A2 (en) 2025-03-26
KR20210018965A (ko) 2021-02-18
AU2019204178B2 (en) 2021-11-18
ES2744979T8 (es) 2020-04-28
CN117660296A (zh) 2024-03-08
JP2019141067A (ja) 2019-08-29
DK3901251T3 (da) 2025-03-03
EP3567099A1 (en) 2019-11-13
ES2876177T3 (es) 2021-11-12
US12409191B2 (en) 2025-09-09
NZ707873A (en) 2019-01-25
HUE054882T2 (hu) 2021-10-28
DK3567099T3 (da) 2021-06-07
US20150246073A1 (en) 2015-09-03
KR20200113287A (ko) 2020-10-06
CN104937095A (zh) 2015-09-23
KR102460536B1 (ko) 2022-10-31
HK1215448A1 (en) 2016-08-26
JP6696023B2 (ja) 2020-05-20
US11369639B2 (en) 2022-06-28
HUE046176T2 (hu) 2020-02-28
EP2912165B1 (en) 2019-06-19
AU2025200927A1 (en) 2025-03-06
RU2015119514A (ru) 2016-12-20
PT2912165T (pt) 2019-09-26
ES3014420T3 (en) 2025-04-22
US10363274B2 (en) 2019-07-30
KR102215476B1 (ko) 2021-02-17
US20220347221A1 (en) 2022-11-03
US20200101112A1 (en) 2020-04-02
KR20150085818A (ko) 2015-07-24
DK2912165T3 (da) 2019-09-16
BR112015009042B1 (pt) 2021-10-19
CN110184232B (zh) 2023-10-20
AU2022201010A1 (en) 2022-03-03
CN110184232A (zh) 2019-08-30
BR112015009042A2 (pt) 2017-07-04
RU2019118791A (ru) 2019-07-11
CA2889270C (en) 2024-09-10
AU2019204178A1 (en) 2019-07-04
US20170281684A1 (en) 2017-10-05
EP2912165A1 (en) 2015-09-02
KR20220150419A (ko) 2022-11-10
ES2744979T3 (es) 2020-02-27
EP3901251B9 (en) 2025-06-18
FI3901251T3 (fi) 2025-03-21
WO2014066699A1 (en) 2014-05-01
EP3901251B1 (en) 2024-12-25
KR102674303B1 (ko) 2024-06-12
KR20240096798A (ko) 2024-06-26
US20250152632A1 (en) 2025-05-15
EP3901251A1 (en) 2021-10-27
CA2889270A1 (en) 2014-05-01
AU2022201010B2 (en) 2024-11-14
CA3240629A1 (en) 2014-05-01
JP6509119B2 (ja) 2019-05-08
JP2016504017A (ja) 2016-02-12
AU2013334276B2 (en) 2019-07-04
SI2912165T1 (sl) 2019-11-29
BR112015009042A8 (pt) 2017-10-10
NZ741724A (en) 2020-02-28
BR122020018576B1 (pt) 2022-07-05
AU2013334276A1 (en) 2015-05-14
EP4527921A3 (en) 2025-05-21
RU2702721C2 (ru) 2019-10-09

Similar Documents

Publication Publication Date Title
PL2912165T3 (pl) Populacje komórek nerkowych i ich zastosowania
SG11201502216UA (en) Cell lines
IL228184B (en) Low fucose cell lines and uses thereof
AU347859S (en) Battery
AU346864S (en) Battery
EP3896152C0 (en) CELLULAR SUSPENSION AND ITS USE
SG11201500417PA (en) Cell culture
IL238880B (en) Systems and methods for electrochemical separation
EP2924787A4 (en) SINGLE CELL OF FUEL CELL
EP2833462A4 (en) SOLID ELECTROLYTE BATTERY
SG11201403144XA (en) Improvements in coating technology
EP2893746A4 (en) SEARCH FOR LOCAL CELL IN AN ENHANCED LOCAL AREA ASSISTED BY A MACRO CELL
EP2904852A4 (en) DETECTION OF SMALL CELLS
EP2939294A4 (en) DRUMS
GB201220058D0 (en) Cell differentiation
EP2843042A4 (en) CELL PREPARATION CONTAINING AN ENGAGED MYOCARDIAL CELL
GB201212550D0 (en) B cell assay
GB201211873D0 (en) Cell culture
GB201218045D0 (en) Battery
GB201218280D0 (en) Photovoltaic cell
PL2683003T3 (pl) Akumulator, zwłaszcza akumulator ołowiowy
GB201203587D0 (en) Modified bacterial cell
GB201214618D0 (en) Double ended cell
GB201218496D0 (en) Cell
GB201221083D0 (en) Electrochemical cells and components thereof